Abstract
BNP or NT-proBNP testing has dramatically changed the management of acute heart failure patients by aiding in early recognition, prognostication and treatment. Furthermore, recent studies have shown that natriuretic peptide testing may guide the therapy of the stable chronic heart failure patients in out-patient setting. We will review the understanding of utilizing natriuretic peptide testing to guide heart failure therapy, including present and future directions for this exciting area.
Keywords: Natriuretic peptides, heart failure, coronary artery disease
Current Clinical Pharmacology
Title: Natriuretic Peptide Guided Heart Failure Management
Volume: 4 Issue: 2
Author(s): Asim A. Mohammed and James L. Januzzi Jr.
Affiliation:
Keywords: Natriuretic peptides, heart failure, coronary artery disease
Abstract: BNP or NT-proBNP testing has dramatically changed the management of acute heart failure patients by aiding in early recognition, prognostication and treatment. Furthermore, recent studies have shown that natriuretic peptide testing may guide the therapy of the stable chronic heart failure patients in out-patient setting. We will review the understanding of utilizing natriuretic peptide testing to guide heart failure therapy, including present and future directions for this exciting area.
Export Options
About this article
Cite this article as:
Mohammed A. Asim and Januzzi Jr. L. James, Natriuretic Peptide Guided Heart Failure Management, Current Clinical Pharmacology 2009; 4 (2) . https://dx.doi.org/10.2174/157488409788184945
DOI https://dx.doi.org/10.2174/157488409788184945 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Editorial (Thematic Issue: The Acute Management of Pediatric Heart Failure)
Current Cardiology Reviews Nonviral Vectors for Cancer Gene Therapy: Prospects for Integrating Vectors and Combination Therapies
Current Gene Therapy "Heart Failure: Meeting the Challenges of Surveillance and Knowledge Translation in Resource-poor Settings"
Current Cardiology Reviews Pleiotropic Effects of ARB on Dyslipidemia
Current Vascular Pharmacology NPY and Receptors in Immune and Inflammatory Diseases
Current Topics in Medicinal Chemistry Matrix Metalloproteinases and their Tissue Inhibitors in Diabetes, Atherosclerosis and Prediction of the Cardiovascular Risk
Current Enzyme Inhibition Hyperuricemia: Is it a Risk Factor for Vascular Endothelial Dysfunction and Associated Cardiovascular Disorders?
Current Hypertension Reviews Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
Current Neuropharmacology Mini Review: Recent Advances in the Cell-Based Therapies for Cardiac Regeneration
Current Stem Cell Research & Therapy Pharmacological Characterisation of Spider Antimicrobial Peptides
Protein & Peptide Letters Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as a New Lead for Treating Breast and Ovarian Cancer
Current Drug Targets Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart Diseases
Cardiovascular & Hematological Disorders-Drug Targets The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis
Current Medical Imaging Heme Oxygenase-1/Carbon Monoxide: Novel Therapeutic Strategies in Critical Care Medicine
Current Drug Targets Endothelin Signalling in the Cardiac Myocyte and its Pathophysiological Relevance
Current Vascular Pharmacology Evolving Concepts Concerning Cardiac β-Adrenoceptor Function in Heart Failure
Current Pharmaceutical Design Meet Our Associate Editor
Current Cardiology Reviews Current Scenario of 1,4-Diazepines as Potent Biomolecules-A Mini Review
Mini-Reviews in Medicinal Chemistry Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging
Mini-Reviews in Medicinal Chemistry Therapeutic Approaches for Reducing C-Reactive Protein (CRP) Levels and the Associated Cardiovascular Risk
Current Chemical Biology